UCB BioSciences GmbH

ACTIVE

Rolf-Schwarz-Schütte-Platz 1, Monheim Am Rhein, Nordrhein-Westfalen, Germanywww.ucb.deSubsidiary

Part of ucb pharma sa (belgium)

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

47.6%

Phase 4

23.8%

Phase 1

19.1%

Phase 2

4.8%

Trial Status Distribution

Completed

95.2%

Withdrawn

4.8%

Clinical Trials

Trials sponsored by this organization (21)

Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS

Phase 3

Completed

interventional

Sep 2015317 participants

Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo

Phase 3

Completed

interventional

Jul 2015736 participants

Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors

Completed

observational

Nov 201493 participants

A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease

Phase 1

Completed

interventional

Sep 201457 participants

Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy

Phase 4

Completed

interventional

Feb 2013122 participants

Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain

Phase 4

Completed

interventional

Nov 201268 participants

A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease

Phase 3

Completed

interventional

Oct 201290 participants

A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease

Phase 4

Completed

interventional

Sep 201287 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations